Taha Qazi, MD: Clinical Considerations for GLP-1 RA Use Before Endoscopy
Qazi discusses a review of considerations for GLP-1 RA use in the context of endoscopic procedures due to their impact on gastric emptying and bowel motility.
Read More
Taha Qazi, MD: Bleeding Risk with Early Versus Late ERCP Following Liver Transplant
Qazi reviews findings from a study exploring the safety of endoscopic retrograde cholangiopancreatography in the early versus late post-transplant period.
Taha Qazi, MD: Assessing Common Causes of Seronegative Villous Atrophy
Qazi reviews findings from a study exploring potential causes of seronegative villous atrophy, emphasizing the importance of maintaining a broad differential in diagnosis.
Taha Qazi, MD: Cuffitis After Pouch Creation and Stricture, Fistula Formation
Qazi discusses implications from a recent study exploring the impact of post-IPAA cuffitis on long-term pouch outcomes and the risk of developing strictures and fistulas.
Taha Qazi, MD: Glucagon for Esophageal Foreign Body Impactions
Qazi reviews findings from a recent study suggesting glucagon does not have a significant impact on esophageal foreign body impaction resolution.
Taha Qazi, MD: Impact of Bariatric Surgery on Cirrhosis, Liver Disease Outcomes
Qazi discusses the impact of bariatric surgery on outcomes in patients with decompensated cirrhosis, highlighting its benefit in this patient population.
Taha Qazi, MD: AGA Guideline’s Impact on Pouchitis, Inflammatory Pouch Disorder Management
Qazi discusses the impact of having standardized definitions and treatment approaches for pouchitis and inflammatory conditions of the pouch.
Taha Qazi, MD: Fenofibrate As First-Line Therapy in Primary Biliary Cholangitis
Qazi discusses a review of the use of fenofibrate as a first-line therapy in treatment-naive patients with PBC and its implications for biochemical response.
Taha Qazi, MD: Using Tofacitinib to Improve Treatment Response in Acute Severe Ulcerative Colitis
Qazi discusses tofacitinib’s role in acute severe ulcerative colitis management as a potential first-line therapy to increase treatment responsiveness.
Taha Qazi, MD: Blue-C Multi-Target Stool DNA Test, Other Noninvasive Options for CRC Screening
Qazi discusses a review of the BLUE-C trial and explains the rise of noninvasive CRC screening and surveillance options, but highlights the need for colonoscopy nonetheless.
Katie Falloon, MD: SEQUENCE and Treatment Positioning
Katie Falloon, MD, discusses findings from the SEQUENCE study, the importance of treatment positioning, and what direct data from head-to-head studies contributes to this understanding.
Shubha Bhat, PharmD: Understanding Etrasimod for Ulcerative Colitis
Shubha Bhat, PharmD, MS, BCACP describes the ELEVATE UC program supporting the FDA approval of etrasimod and the current understanding of treatment positioning between etrasimod and ozanimod.
Taha Qazi, MD: Evolving Bariatric Surgery Value in GI
Data support the benefit of bariatric surgery in patients at high risk of pancreatic ductal adenocarcinoma due to BMI and metabolic comorbidities.
Taha Qazi, MD: Addressing Smoking Cessation in the GI Office
Qazi reviews an analysis of an EHR-assisted smoking cessation module that could improve conversations between specialists and patients.
Taha Qazi, MD: Best Screening for Colorectal Cancer
While discussing a review of noninvasive options, the gastroenterologist addresses the growing interest in non-colonoscopy screening and surveillance methods.
Taha Qazi, MD: Finding Upadacitinib's Role in Crohn's Disease
Qazi reviews the selective JAK1 inhibitor's benefit for patients who previously failed TNF inhibitor regimen.
Introducing The Qazi Corner: A Gastroenterology Newsletter Featuring Taha Qazi, MD
The Qazi Corner will be a quarterly newsletter led by Taha Qazi, MD, of the Cleveland Clinic and featuring new data, conference highlights, and perspectives of leading gastroenterologists.
